Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Delhi High Court:...

    Delhi High Court: E-pharmacies claim they are like Swiggy, only deliver drugs

    Farhat NasimWritten by Farhat Nasim Published On 2019-07-04T17:04:54+05:30  |  Updated On 4 July 2019 5:04 PM IST
    Delhi High Court: E-pharmacies claim they are like Swiggy, only deliver drugs

    The e-pharmacies told a bench of Chief Justice D N Patel and Justice C Hari Shankar that just like Swiggy does not require a restaurant license to deliver food, they do not require any license to deliver medicines to customers who purchase drugs online.


    New Delhi: E-pharmacies on Thursday told the Delhi High Court that they do not require a license for the online sale of drugs and prescription medicines as they do not sell them, instead they are only delivering the medications akin to food-delivery app Swiggy.


    The e-pharmacies told a bench of Chief Justice D N Patel and Justice C Hari Shankar that just like Swiggy does not require a restaurant license to deliver food, they do not require any license to deliver medicines to customers who purchase drugs online.


    The submission came during the hearing of a plea seeking contempt action against the e-pharmacies for continuing to sell drugs online despite a high court order staying such activity.


    The petition also seeks contempt action against the central government for allegedly not taking any action against the defaulting e-pharmacies.


    Also Read: Final regulations on e pharmacy likely by December-end, says DCGI


    The central government, in its defense, told the court that framing of rules to regulate e-pharmacies was under consideration and consultations were being held with all the stakeholders.


    Several of the e-pharmacy companies and the Centre also sought time to file their response to the contempt plea.


    Subsequently, the bench granted them time till September 24, the next date of hearing.


    The contempt plea was filed by Zaheer Ahmed who had earlier moved a PIL seeking a ban on "illegal" sale of drugs online.


    The high court had earlier stayed the sale of drugs and prescription medicines by online pharmacies while hearing Ahmed's PIL.


    In his earlier petition, he has said that the online illegal sale of medicines would lead to a drug epidemic, drug abuse and misutilization of habit forming and addictive drugs.


    The PIL has said that since there was no mechanism to control the sale of medicines online, this puts health and lives of people at high risk and affects their right to a safe and healthy life under Article 21 of the Constitution.


    "Online pharmacies are operating without a drug licence and cannot be regulated in the present regime. Unregulated and unlicensed sale of medicines will increase risk of spurious, misbranded and sub-standard drugs being sold," the plea has said.


    Also Read: Relief for online pharmacy traders: Madras High Court vacates stay on sale of online drugs

    Delhidrug licensee-pharmaciese-pharmacyepharmaciesHigh Courtonlineonline drugsOnline PharmacyPILprescription medicinesSwiggyzaheer ahmed
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok